These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3813188)

  • 41. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
    Noori S; Friedlich P; Wong P; Garingo A; Seri I
    Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.
    Rich S; Brundage BH; Levy PS
    Circulation; 1985 Jun; 71(6):1191-6. PubMed ID: 3995712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 44. Vasodilator therapy for primary pulmonary hypertension.
    McGoon MD; Vlietstra RE
    Mayo Clin Proc; 1984 Oct; 59(10):672-7. PubMed ID: 6148467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
    Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary pulmonary hypertension. Aminophylline].
    Klein W
    Wien Z Inn Med; 1969; 50(10):499-501. PubMed ID: 5406763
    [No Abstract]   [Full Text] [Related]  

  • 49. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
    Ricksten S
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of isosorbide dinitrate on the pulmonary arterial system in patients with pulmonary hypertension (author's transl)].
    Hoshino T; Handa S; Akizuki S; Hori S; Norisue H; Hori A; Fukui T
    Kokyu To Junkan; 1981 Mar; 29(3):291-5. PubMed ID: 7255981
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
    Yamazaki Y; Matsumoto H; Takeda A; Takahashi T; Sasaki N; Takahashi M; Tsuji T; Fujikane T; Shimizu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Aug; 35(8):847-53. PubMed ID: 9366158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of vasodilator therapy on the limb circulation in hypertension.
    Váradi A; Solti F; Iskum M
    Acta Med Hung; 1990; 47(3-4):157-62. PubMed ID: 2130363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on the drug therapy of pulmonary hypertension].
    Heimburg P; Neubaur J
    Verh Dtsch Ges Inn Med; 1971; 77():1315-8. PubMed ID: 5156015
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary pulmonary hypertension: recent advances.
    Rich S
    Herz; 1986 Aug; 11(4):197-206. PubMed ID: 3530928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
    Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
    Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nifedipine in the treatment of pulmonary hypertension. I--Primary pulmonary hypertension].
    Barreto SM; de Freitas FM
    Arq Bras Cardiol; 1986 May; 46(5):359-64. PubMed ID: 3551892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.